Hot Flasher

Hot Flasher
  • 5.0 (2)
  • Sexuality
  • Updated Daily

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

  1. Aug 28

    Move for Your Mood, Skin That Shifts, and a Story That Matters

    This episode covers a new network meta-analysis on which types of exercise help most with anxiety and depression after menopause — and how much you actually need. It also looks at what menopause does to your skin and why doctors rarely explain it, and opens up a conversation about women navigating menopause while also dealing with unsafe home situations. Key Takeaways: • Mind-body exercise (yoga, tai chi, qigong) ranked highest for reducing anxiety in postmenopausal women in a 2026 network meta-analysis; aerobic exercise ranked highest for depression. • The dose-response data suggests more exercise helps up to a point — but moderate amounts showed meaningful benefits, meaning you don't need to overtrain to see mood effects. • Falling estrogen directly affects skin: it thins the outer layer, slows collagen production, and reduces moisture retention — changes that are hormonal, not just aging. • Women experiencing intimate partner violence face compounded barriers to menopause care, including inability to attend appointments, access medications, or safely discuss symptoms — a gap the healthcare system largely ignores. • The NAMS journal publishing on IPV and menopause together is itself significant — it signals the field is starting to take the social context of care seriously. Sources & References: • Exercise types and dose-response for anxiety and depression in postmenopausal women — network meta-analysis (2026) (https://pubmed.ncbi.nlm.nih.gov/42656382/) - PubMed • Menopause and skin — NAMS Journal (https://pubmed.ncbi.nlm.nih.gov/42647388/) - Menopause (NAMS Journal) • The overlooked intersection of intimate partner violence and menopause care (https://pubmed.ncbi.nlm.nih.gov/42610458/) - Menopause (NAMS Journal) Listen with full show notes: https://hotflasher.com/episodes/2026-08-28-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  2. 23h ago

    Reddit Knows, Bosses Don't, and Your Mood Isn't Just In Your Head

    This episode covers a STAT News opinion piece by a researcher who analyzed Reddit menopause forums to surface symptoms doctors rarely ask about, a new systematic review linking hot flashes and night sweats to depression and anxiety, and the story of a beauty therapist fired after requesting flexible hours due to severe menopause symptoms. Key Takeaways: • A researcher studying Reddit menopause forums found a significant gap between the symptoms women frequently describe online and what clinicians actually measure or ask about in studies and appointments. • A 2026 systematic review of observational studies found a consistent association between hot flashes and night sweats and higher rates of depression and anxiety in peri- and postmenopausal women — not proof of cause and effect, but a strong enough pattern across multiple studies to take seriously. • The mood-symptom connection likely runs in both directions: hot flashes may worsen mood, and mood disorders may make women more sensitive to hot flashes. • Chantelle Van Vliet, a beauty therapist, was fired after requesting flexible hours to manage severe menopause symptoms — a workplace discrimination case that highlights how little legal and institutional protection many women still have around menopause. • There is currently no federal menopause-specific workplace protection in many countries, meaning women often have to rely on broader disability or health accommodation frameworks — which don't always fit or succeed. Sources & References: • Opinion: I studied Reddit forums on menopause — and found what doctors are missing (https://www.statnews.com/2026/08/27/menopause-perimenopause-symptoms-reddit-clinical-data-study/) - STAT News • Vasomotor symptoms and their association with depressive and anxiety symptoms in peri- and postmenopausal women: A systematic review (https://pubmed.ncbi.nlm.nih.gov/42654471/) - PubMed • Beauty therapist Chantelle Van Vliet was fired after asking for flexible hours over severe menopause symptoms (https://news.google.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) - The Times of India via Google News Listen with full show notes: https://hotflasher.com/episodes/2026-08-27-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  3. 1d ago

    Viagra for Women, Shingles Shots, and the Menopause Story Nobody Asks About

    This episode covers three stories that challenge what most people think menopause care is actually about. We look at a new phase one safety trial of topical sildenafil cream for postmenopausal women, a NAMS paper on how intimate partner violence intersects with menopause care, and new Oxford research linking the Shingrix shingles vaccine to lower heart disease and dementia risk. Key Takeaways: • A phase 1 trial published August 2026 found topical sildenafil cream was safe and absorbed well in postmenopausal women — it's early-stage research, but the mechanism is sound and the need is real. • The shingles vaccine Shingrix has now been linked to lower risk of both heart disease and dementia in a large Oxford "natural experiment" — it may be doing more than preventing a painful rash. • A new NAMS paper makes the case that menopause clinicians need to be screening for intimate partner violence, because the hormonal and psychological shifts of menopause can escalate existing abuse and also be weaponized against women seeking care. • Female sexual dysfunction affects an estimated 40% of postmenopausal women, and until recently the clinical pipeline has been nearly empty — topical sildenafil is not a cure, but it represents the field finally taking the problem seriously. • The Shingrix-heart disease finding comes from observational data, not a clinical trial, so causation isn't proven — but the consistency with the earlier dementia finding makes it worth paying attention to, especially since most midlife women should be getting the vaccine anyway. Sources & References: • Topical sildenafil cream safety study in postmenopausal women (Phase 1) (https://pubmed.ncbi.nlm.nih.gov/42639865/) - PubMed • The overlooked intersection of intimate partner violence and menopause care (https://pubmed.ncbi.nlm.nih.gov/42610458/) - Menopause (NAMS Journal) • Shingrix linked to lower heart disease risk in new Oxford study (https://www.statnews.com/2026/08/26/shingles-vaccine-shingrix-reduces-heart-disease-dementia-risk-oxford-study/) - STAT News Listen with full show notes: https://hotflasher.com/episodes/2026-08-26-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  4. 2d ago

    Your Mouth Is On Fire and Science Is Just Now Paying Attention

    This episode covers three new studies published in August 2026. Nykki looks at how common different menopause symptoms actually are, digs into a new hypothesis linking burning mouth syndrome to brain changes during menopause, and stress-tests a seaweed compound that's being studied for bone loss — with a clear verdict on what women can actually do with that information right now. Key Takeaways: • Hot flashes and night sweats are the most commonly reported menopause symptoms, but sleep problems, joint pain, and mood changes are close behind — a 2026 study confirms how wide the symptom picture really is. • Burning mouth syndrome — a persistent burning sensation in the mouth with no obvious dental cause — may be connected to nerve and brain changes triggered by estrogen loss, according to a new hypothesis paper. It's not imagined, and it's not a dental problem. • The proposed link between burning mouth syndrome and neurodegeneration is early-stage and theoretical. It does not mean burning mouth predicts dementia — it means researchers are asking a new and serious question. • Fucoidan, a compound found in giant kelp, reduced bone loss markers in a postmenopausal mouse study by influencing signaling pathways that control how bone is broken down and rebuilt. This is mouse-model research — no human trial yet. • If you have persistent mouth burning, the right first step is ruling out dental and nutritional causes with a doctor, then asking about referral to an oral medicine specialist — not waiting for this research to mature. Sources & References: • Prevalence and associated factors of menopausal symptoms among women (2026) (https://pubmed.ncbi.nlm.nih.gov/42638248/) - PubMed • Menopause, neurodegeneration and burning mouth syndrome: a hypothesis-generating perspective (2026) (https://pubmed.ncbi.nlm.nih.gov/42638187/) - PubMed • Fucoidan from giant kelp alleviates postmenopausal osteoporosis by regulating bone signaling pathways (2026) (https://pubmed.ncbi.nlm.nih.gov/42637471/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-25-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  5. 3d ago

    Your Heart, Your Blood Pressure, and the Drug Your Doctor Just Prescribed

    This episode covers three new studies from the NAMS journal. First, a large cohort study showing that premature menopause combined with high blood pressure creates cardiovascular risk far beyond either condition alone. Then, a paper raising a largely invisible issue — how intimate partner violence shapes whether and how women access menopause care. And finally, real-world safety data on fezolinetant (Veozah), the non-hormonal hot flash drug, showing its clinical trial safety profile mostly holds up in the real world — with a few signals worth watching. Key Takeaways: • Women who experienced premature menopause (before 40) AND have high blood pressure face cardiovascular risk significantly higher than either factor alone — making menopausal age a data point your cardiologist should know. • Most standard menopause care doesn't account for whether a woman is safe at home — and intimate partner violence directly affects whether she can access, afford, or safely use treatment. • Fezolinetant's (Veozah) real-world safety data broadly matches what clinical trials found, but there are disproportionate signals around liver and neurological events that warrant ongoing monitoring. • The fezolinetant pharmacovigilance analysis uses a WHO reporting database — it can flag patterns worth investigating, but it can't tell you how common these events actually are. • Knowing your age at menopause — especially if it was early — is medically relevant information for heart disease prevention, not just reproductive history. Sources & References: • Premature menopause and hypertension as combined cardiovascular risk factors: nationwide cohort analysis (https://pubmed.ncbi.nlm.nih.gov/42549666/) - PubMed / Menopause (NAMS Journal) • The overlooked intersection of intimate partner violence and menopause care (https://pubmed.ncbi.nlm.nih.gov/42610458/) - PubMed / Menopause (NAMS Journal) • Real-world safety signals of fezolinetant in women with menopausal vasomotor symptoms: WHO VigiAccess pharmacovigilance analysis (https://pubmed.ncbi.nlm.nih.gov/42610452/) - PubMed / Menopause (NAMS Journal) Listen with full show notes: https://hotflasher.com/episodes/2026-08-24-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  6. 6d ago

    When Menopause Gets Dark: Suicidality, Bone Clues & a Big New Study

    This episode covers a qualitative study on how fragmented care systems fail women experiencing suicidality during menopause, a promising new blood marker for detecting bone thinning early, and the launch of one of the most detailed long-term menopause studies ever designed. Friday format — research grounded, lighter in places, and worth your weekend thinking. Key Takeaways: • A 2026 qualitative study found that clinicians and caregivers consistently identified fragmented, siloed care as a key failure point when menopausal women reached a mental health crisis — menopause and mental health services often don't talk to each other. • Suicidality during perimenopause and menopause is real and documented, but it remains dramatically undertreated and under-recognized in primary care. • Xylosyltransferase-I (XT-I) is a blood enzyme that may signal bone thinning earlier than current standard tests — still early-stage research, but worth watching. • The KiSO-DP cohort study will track women through the full menopausal transition using biological, psychological, and lifestyle data collected from the same participants over time — the kind of within-person design that produces much more reliable answers than snapshot studies. • Research on menopause is getting more ambitious and more rigorous — and the questions being asked are finally catching up to what women have been reporting for decades. Sources & References: • Menopausal suicidality and fragmented care: carer and clinician perspectives (https://pubmed.ncbi.nlm.nih.gov/42625547/) - PubMed • Xylosyltransferase-I as a biomarker for postmenopausal osteoporosis (https://pubmed.ncbi.nlm.nih.gov/42624941/) - PubMed • KiSO-DP: Women in healthy transition deep phenotyping cohort study protocol (https://pubmed.ncbi.nlm.nih.gov/42624590/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-21-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  7. Aug 20

    35 Lost Workdays, Stolen Sleep, and the Story Nobody's Telling

    This episode covers three things getting attention right now: new data showing menopause symptoms cost workers nearly 35 workdays a year, a 2026 study linking menopausal insomnia directly to dementia risk, and a NAMS journal paper raising the intersection of intimate partner violence and menopause care — a conversation that's been missing from the field for too long. Key Takeaways: • New research estimates that perimenopause and menopause symptoms cost employees nearly 35 workdays per year in lost productivity — not just absences, but impaired performance while present. • A 2026 PubMed study frames menopausal insomnia as a point in the chain leading to dementia risk — and, critically, as something that can be addressed, which means sleep isn't just about feeling rested. • Poor sleep during menopause disrupts the brain's overnight cleanup process, which is directly tied to the kind of protein buildup associated with Alzheimer's disease. • A paper in the NAMS journal identifies intimate partner violence as an underexplored factor in menopause care — abuse affects stress hormones, sleep, and access to healthcare in ways that can make symptoms significantly worse. • Women in abusive situations may have their menopause symptoms dismissed, undertreated, or go entirely unaddressed — and clinicians currently have almost no training to recognize the overlap. Sources & References: • Perimenopause and menopause symptoms may cost employees nearly 35 workdays a year (https://news.google.com/rss/articles/CBMitAFBVV95cUxNY0RIMzI2ZmlSdXhsV2k4LW5oeFoxTmhOaFEyeU1TdDR5NXVXUU5zQWNWOEJaMC1abVFGQkM4U1hXb0tuNUwxbFFXM2V3MndIMW5GRTBreC05ck5RUENLa2g0SmpsSjNlZFVCQ3g0RU5RZzhZRUs5QmRIRDdVLWgxUzdoamRFZ1FTWkJYMG5aSU12OTJwNUpBNlJVeV9iQkZGN2NtMlhUc0NnbEo2aEUzSWJWMzQ?oc=5) - Fast Company • Menopausal insomnia as a modifiable node of dementia risk: Mechanistic insights and intervention strategies (https://pubmed.ncbi.nlm.nih.gov/42619312/) - PubMed • The overlooked intersection of intimate partner violence and menopause care (https://pubmed.ncbi.nlm.nih.gov/42610458/) - Menopause (NAMS Journal) Listen with full show notes: https://hotflasher.com/episodes/2026-08-20-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  8. Aug 19

    The Menopause Market Is Booming. Here's What's Actually Worth Your Money.

    JAMA takes a hard look at the exploding menopause care market and asks which treatments actually have evidence behind them. A new NAMS study finds that type 2 diabetes significantly worsens menopause symptoms — more than most people realize. And a peer-reviewed paper asks why clinicians almost never screen for intimate partner violence during menopause care visits. Key Takeaways: • The menopause care market is growing fast, but JAMA's review finds the evidence for many emerging treatments hasn't kept pace with the marketing. • Hormone therapy and a small number of non-hormonal options have the strongest research backing; most supplements and "menopause kits" do not. • A Korean study of midlife women found that those with type 2 diabetes reported significantly more menopause symptoms — and more severe ones — than women without diabetes. • Postmenopausal women with type 2 diabetes had a higher overall symptom burden, suggesting blood sugar management may directly affect quality of life during menopause. • Research published in the NAMS journal finds that clinicians rarely screen for intimate partner violence during menopause care visits, despite evidence that IPV affects both access to care and symptom severity. Sources & References: • The overlooked intersection of intimate partner violence and menopause care (https://pubmed.ncbi.nlm.nih.gov/42610458/) - Menopause (NAMS Journal) • Association between type 2 diabetes and menopausal symptoms in Korean midlife women (https://pubmed.ncbi.nlm.nih.gov/42549660/) - Menopause (NAMS Journal) Listen with full show notes: https://hotflasher.com/episodes/2026-08-19-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

See All (112)

Ratings & Reviews

5
out of 5
2 Ratings

About

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

Information

  • Creator
    Hot Flasher
  • Years Active
    2026
  • Episodes
    112
  • Rating
    Clean
  • Show Website
    Hot Flasher